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Abstract
Objective: Glioblastoma multiforme (GBM), one of the most common and aggressive 
malignant brain tumors, is highly resistant to radiotherapy. Numerous approaches have 
been pursued to find new radiosensitizers. We used a picogreen and colonogenic assay 
to appraise the DNA damage and cell death in a spheroid culture of GBM cells caused by 
iodine-131 (I-131) beta radiation in the presence of topotecan (TPT).
Materials and Methods: U87MG cells were cultured as spheroids with approximate 
diameters of 300 μm. Cells were treated with beta radiation of I-131 (at a dose of 2 Gy) 
and/ or TPT (1 μg/ml for 2 hours). The numbers of cells that survived were compared with 
untreated cells using a colonogenic assay. In addition, we evaluated possible DNA dam-
ages by the picogreen method. The relation between DNA damage and cell death was 
assessed in the experimental study of groups.
Results: The findings showed that survival fraction (SF) in the I-131+TPT group 
(39%) was considerably less than the I-131 group (58.92%; p<0.05). The number of 
single strand breaks (SSB) and double strand breaks (DSB), in  the DNA of U87MG 
cells treated with beta radiation of I-131 and TPT (I-131+TPT) significantly increased 
compared to cells treated with only I-131 or TPT (p<0.05). The amount of SSB re-
pair was more than DSB repair (p<0.05). The relationship between cell death and 
DNA damage was close (r≥0.6) and significant (p<0.05) in the irradiated and treated 
groups. Also the maximum rate of DNA repair occurred 24 hours after the treatments. 
A significant difference was not observed on other days of the restoration.         
Conclusion: The findings in the present study indicated that TPT can sensitize 
U87MG cells to radiation and increase DNA damages. Potentially, TPT can cause 
an increase in damage from DSB and SSB by its inhibitory effects on topoisomerase 
enzyme and the cell cycle. The increased complex damages following the use of a 
genotoxic agent and beta I-131 radiation, causes a significant increase the cell death 
because of the difficult repair process. By assessing the relationship between DNA 
damage and cell death, the picogreen method can be useful in predicting colonogenic 
assay. Consequently, it is suggested that co-treatment with I-131 beta radiation and 
TPT can improve GBM treatment.          
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Introduction
Glioblastoma multiform (GBM) is one of the 
most frequent, malignant primary brain tumors in 
adults (1, 2). The approximate incidence of malig-
nant glioma is 5 per 100,000 people worldwide, 
and it is more common among Americans and 
Africans (1, 3). Due to lack of an effective treat-
ment, there is little hope for patients with GBM. 
After surgery, radiotherapy is the most effective 
treatment strategy for these patients (4, 5). GBM 
tumors hypoxia leads to resistance to radiotherapy, 
and several attempts have been made to design ef-
fective radiosensitizers (1).
Topotecan (TPT), as a radiosensitizer agent, is a 
recent chemotherapy drug derived from the Chi-
nese tree Camptotheca acuminata (6, 7). TPT stops 
the cell cycle through inhibition of topoisomerase 
I (Topo-I) enzyme activity. Inhibition of the cell 
cycle by this enzyme will lead to DNA phospho-
rylation, which in turn increases both the DNA-
Topo І complex and double strand breaks (DSB), 
which finally lead to apoptotic death (4, 7, 8).
In order to increase the survival time for GBM 
patients, research has shown that the combination 
of low linear energy transfer radiation (LET) with 
TPT could result in only an increase of 1-2 years 
in survival (9, 10).
This issue motivates researchers to use a com-
bination of TPT with high LET radiation. On the 
other hand, little information is available regard-
ing the mechanism of changes in the cell nuclei by 
TPT on cancer cells of different organs.
 Recent radiotherapy and chemotherapy studies 
have shown that best results were achieved when 
TPT was injected 2-4 hours prior to radiation (11, 
12). Rave-Frank et al. (13) showed that combined 
radiation and TPT treatment lead to reduction of 
colonogenic cell survival in glioblastoma cells. 
McCluskey et al. (14) reported that simultaneous 
administration of PJ34 and (131) I-meta-iodoben-
zylguanidine/TPT [(131) I-MIBG/TPT] induced 
supraadditive toxicity in noradrenaline transporter 
(NAT) - transfected glioma cells.
Iodine-131 (I-131) is one of the radioisotopes 
which emits beta and gamma rays. The principal 
radiant that causes damage is the beta ray. Beta 
rays have more ionizing power in comparison 
with the X photon. Their prominent advantage in 
cellular damage is based on crossfire phenomenon; 
in which rays with several cell depths transfer en-
ergy to neighboring and distant cells (cross-dose) 
in addition to creating self-dose in surrounding 
cells. This phenomenon increases DNA breaks. If 
the cancer cells receive less self-dose, it will be 
compensated by a cross-dose (15). This is particu-
larity important in tumor treatment and has been 
widely used in the treatment of thyroid and central 
nervous system (CNS) tumors (16). Previous ex-
perimental study has also shown that the combi-
nation of chemotherapeutic agents with high-LET 
particle beams can enhance the cellular effect that 
is comparable to photon irradiation (17).
Direct or indirect interaction of ionizing radia-
tion induces a variety of DNA damage such as 
single strand breaks (SSB), DSB, base damage 
(BD) of various types and DNA-protein cross-
links (18). We have used the picogreen method as 
a suitable tool to determine the single strand DNA 
(ssDNA)/ double strand DNA (dsDNA) ratio and a 
sensitive probe for determing the level of damage 
to dsDNA. The fast micromethod was introduced 
by Batel et al. (19) and subsequently modified for 
analyzing high number of samples in a short time. 
The colonogenic assay is also appropriate to 
ensure that radiation-induced DNA damage leads 
to cell death. Although numerous papers have re-
ported the relationship between colonogenic radi-
osensitivity, radiation induced apoptosis and DNA 
damage, other methods such as the comet assay 
and γH2AX are also used (20, 21).
The primary objective of this study was to inves-
tigate the impact of TPT co-treatment with I-131 
beta radiation therapy on DNA damage, repair of 
damage and cell death in GBM cells using the pi-
cogreen and colonogenic assays. This study also 
compared these two techniques.
Materials and Methods
Cell line
The human GBM cell line U87MG was pur-
chased from Pasteur Institute of Iran. This cell 
line was cultured in minimum essential medium 
(MEM; Gibco/Invitrogen, USA) that contained 
10% fetal bovine serum (FBS; GmbH/ PAA, Aus-
tria), 100 U/ml of penicillin streptomycin (GmbH/
PAA, Austria) and 20 U/ml of fungizone (Gibco/
Invitrogen, USA).
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Monolayer culture
In the experimental study, cells were cultured 
as a monolayer at a density of 25×104 cells/cm2 
in T-25 tissue culture flasks (NEST).Cultures were 
maintained at 37˚C in a humidified atmosphere 
and 5% CO2. Cells were harvested by trypsinizing 
cultures with 0.25% trypsin (Sigma/Aldrich, Ger-
many) and 0.03% ethylenediaminetetraacetic acid 
(EDTA; Sigma/Aldrich, Germany) in phosphate-
buffered saline (PBS; MP Biomedicals, Germany).
Spheroid culture
Spheroids were cultured using the liquid overlay 
technique. A total of 5×105  cells were seeded into 
NEST coated with a thin layer of 1% agar (Sigma/
Aldrich, Germany) with 10 ml of MEM supple-
mented with 10% FBS. The plates were incubated 
at 37˚C in a humidified atmosphere and 5% CO2 
(Memmert, Germany). Half of the culture medi-
um was replaced with fresh culture medium every 
three days.
Growth curve
After three passages of monolayer culture, the cells 
were cultured at a density of 10000 per well in mul-
tiwell plates (24 wells/plate; Greiner). The multiwall 
plates were incubated at 37˚C in a humidified atmos -
phere and 5% CO2. For a nine days period, at 24 hour 
intervals, the cells from the triplicate wells were re-
moved with 1mM EDTA/0.25% trypsin (w/v) treat-
ment and counted in a hemocytometer. An average of 
nine counts was used to define each point [mean ± 
standard error mean (SEM)]. Half of the culture medi-
um was replaced with fresh medium twice per week. 
We plotted a growth curve where in the linear area or 
logarithmic phase of the curve, we calculted the cell 
numbers as follows: N=N0×ebt, in which "N0" is the 
initial number of the cells, "N" is the number of the 
cells after time, "t" and "b" shows the gradient of the 
logarithmic phase of the curve. Then, the population 
doubling time of the cells was determined according 
to the gradient of the logarithmic phase of the curve.
To draw the spheroid growth curve, one spheroid 
cell was seeded per well in multi-well plates coated 
with a thin layer of 1% agar with 1 ml of MEM. The 
multi-well plates were incubated at 37˚C in a humidil-
fied atmosphere and 5% CO2. For 28 days, at 72 hour 
intervals, we measured the vertical diameters of the 
cells by a microscope. The measurements were per-
formed in triplicate. Next, the cell volume were cal-
culated according to the formula V= a.b2.π/6, where 
"a" is the small diameter of the cells, "b" is the large 
diameter of the cells and "V" shows the volume of the 
spheroid cells. An average of nine counts was used to 
define each point (mean ± SEM). Half of the culture 
medium was replaced with fresh medium twice per 
week. Next, we plotted the growth curve, where in 
the linear area or logarithmic phase of the curve, we 
calculated the volume of cells as follows: V=V0× e 
kt, 
in which "V0" is the initial volume of the cells, "V" is 
the volume of cells after time, "t" and "k" shows the 
gradient of the logarithmic phase of the curve. Then, 
the volume doubling time (VDT) of the cells was de-
termined according to the gradient of the logarithmic 
phase of the curve.
Drug treatment and beta cell irradiation by I-131
The GBM cells were grown on a layer as three di-
mensional spheroid cells (diameters: approximately 
300 μm) in a liquid method. We divided the cells into 
four groups: i. control, ii. TPT: cells treated with 1 μg/
ml of TPT for 2 hours, iii. I-131: cells incubated with 
a solution of 10 mci (millicurie) I-131 in 0.2 M NaOH 
for 108 minutes and iv. I-131+TPT: cells incubated 
with a solution of 10 mci I-131 in 0.2 M NaOH for 
108 minutes after which they were treated with TPT 
for 2 hours. The flask was exposed for 108 minutes to 
determine the correlation between DNA damage and 
the absorbed dose of 2 Gy (22). 
Subsequently the flasks that contained medium 
were centrifuged, then cells washed and centrifuged 
twice with PBS to remove the I-131. At the end of the 
exposure and treatment periods, we evaluated DNA 
damage by the picogreen method. Groups three and 
four were assessed for DNA damage daily for seven 
days after the treatments. The colonogenic ability of 
cells was evaluated by colony assay in groups one, 
three and four.
Picogreen assay
The picogreen assay is an easy, rapid, and sen-
sitive micromethod that determines the extent of 
DNA damage (DSB, SSB) in individual cells, induced 
by a variety of genotoxic agents (22, 23).  We used the 
picogreen assay to evaluate radiation-induced SSB 
and DSB damages in the DNA of GBM cells accord-
ing to a protocol as previously mentioned by Schroder 
et al. (24). The solutions used are as follows. A fluo-
rescent dye stock solution was the picogreen dsDNA 
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quantitation reagent (solution A; Life Technology/
Invitrogen, USA). Calcium (Ca) and magnesium 
(Mg) free PBS (Ca/Mg free PBS) consisted of 
137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 
and 1.5 mM KH2PO4 (solution B; Gibco/Invitro-
gen, USA). The lysing solution contained 9.0 M 
urea, 0.1% sodium dodecyl sulfate (SDS) and 0.2 
M EDTA at a pH of 10 with NaOH (solution C; 
Sigma/Aldrich, Germany). Lysing solution sup-
plemented with picogreen consisted of 10 μL of 
the original stock dye/ml of solution C (solution 
D; Life Technology/Invitrogen, USA). Solution 
E (Sigma/Aldrich, Germany) consisted of 20 mM 
EDTA and solution F (Gibco/Invitrogen, USA) 
consisted of an NaOH stock solution (1.0 M NaOH 
and 20 mM EDTA). The working NaOH solution 
was prepared fresh prior to use. A total of 2 mL of 
solution F was added to 18 mL of solution E with a 
pH of 12.40 ± 0.02 to create solution G.
In order to determine the DSB induced in GBM 
cells, 3 falcon pipes that consisted of 50,000 cells/
mL with 300 µl of solution C and 300 µl of solu-
tion D. in order to lyse the cells, these groups were 
placed in the dark for 40 minutes. The amount of 
DSB was determined after 40 minutes by using a 
485 nm excitation wavelength and 528 nm emis-
sion wavelength.
Next, 50 μl of solution G was added to 600 μl 
of the lysed cells in each group (control, irradi-
ated and treated+irradiated). The amount of SSB 
were determined after three hours of incubation 
by measuring the fluorescence intensity of each 
group.
Calibration curve
The various concentrations of DNase with 300 μl of 
solution D and a given volume of PBS (final reaction 
volume: 800 µL) were added to various concentra-
tions of non-irradiated GBM cells. Next, the amount 
of fluorescence intensity for digestion DNA in each 
group was measured after three hours of incubation.
Colonogenic assay
The colonogenic assay determines cell death fol-
lowing radiation (25). We evaluated the colonogenic 
ability and surviving fraction of GBM cells by the 
colony assay according to the manufacturer’s proto-
col by Franken et al. (26). Treated cells from each of 
the groups were seeded at the  appropriate concen-
trations into 25 cm2 flasks. Colonies are fixed with 
formaldehyde (Gibco/Invitrogen, USA) 0.2% v/v for 
five minutes, stained with crystal violet (0.5% w/v) 
for forty minutes, and counted using an optical mi-
croscope (Techno/Meiji, Japan). Colonies were de-
fined as cell aggregates the approximate number of 
which was more than 50. We calculated the number of 
colonies, plating efficiency (PE) and survival fraction 
(SF). The PE is the ratio of the number of colonies 
to the number of cell seeds. Colonogenic efficiency 
is the SF, which is defined as the PE in treated cells 
divided by the PE in untreated cells. The SF was cal-
culated after determining PE.
Statistical analysis
Statistical analysis was performed using the in-
dependent-samples t test and one-way analysis of 
variance (ANOVA) followed by the scheffe test as 
the post-hoc analysis using statistical package for 
the social sciences (SPSS) version 16. Pearson’s 
correlation coefficient was used to determine the 
relationship between cell death and DNA damage. 
P<0.05 was considered to be significant. All values 
are expressed as mean ± S.E.M for all tests.
Results
Cell characteristics
Monolayer culture
The U87MG GBM cell line grows as a monolayer 
in the tissue culture flasks. The growth curve of these 
cells in the monolayer culture is shown in figure 1. 
The population doubling time calculated from this 
curve was approximately 25.9 ± 0.39 hours (Fig.1).
Spheroid cult Spheroid culture
The U87MG cells formed spheroids in the liq-
uid overlay cultures. The volume doubling time of 
these spheroids is approximately 58.77 hours (Fig.2).
DSB and SSB  
The picogreen assay was used to determine the 
extent of SSB and DSB damage. The spectrum was 
derived from samples of the irradiated, treated and 
control groups of U87MG cells of 300 µm sphe-
roids. We used the spectroflourometer (Shimadzu, 
Japan) at an excitation wave length of 485 nm and 
eoups. This reduction showed DSB and SSB dam-
ages in irradiated and treated GBM cells.
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Fig.1: Growth curve of U87MG cell line in the monolayer cultures. An average of nine counts was used to define each point. Mean ± SEM 
of three experiments. 
Y; Number of cell, X; Time (day), R; Regression coefficient and SEM; Standard error of the mean.
Fig.2: Growth curve of U87MG cell line in spheroid Cultures. An average of nine counts was used to define each point. Mean ± SEM of 
three experiments is shown on the curve.
Y; Volume (µm3), X; Time (day), R; Regression coefficient and SEM; Standard error of the mean.
Table 1: The measured average fluorescence intensities of control glioblastoma (GBM) cells and those irradiated by 2 G y of beta io-
dine-131, (I-131) to determine the amount of single-strand breaks (SSB) and double-strand breaks (DSB) in presence topotecan (TPT)
Fluorescence (SSB) (nm) Fluorescence (DSB) (nm)Group
496.64 ± 3.50595.72 ± 3.32Control
482.00 ± 2.32567.00 ± 3.20TPT
428.50 ± 2.50490.00 ± 1.74I-131
411.00 ± 2.81455.00 ± 2.32I-131+TPT
Data are presented as mean ± standard error of the mean (SEM). 
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A calibration curve was drawn to measure SSB 
and DSB in the cell group. To plot the curve, the 
average amounts of fluorescence intensity were 
derived from the control and treated groups. The 
average fluorescence intensity in the control group 
in compared to the treated groups was significantly 
differed (p<0.05). A gradient of the linear phase of 
the curve showed a 1% break in DNA. The differ-
ence of intensity per break in the DNA strand was 
341.5, which meant that for each 3.415 change 
in amount of fluorescence intensity, a 1% break 
would occur in the DNA strand. The calibration 
curve is shown in figure 3.
The difference between average intensities in the 
control and treated groups was divided by 3.4 to de-
termine the percent of SSB and DSB damage (Fig.4).
Figure 4 shows that I-131+TPT had significantly 
increased DSB and SSB damage in compared to 
the  I-131 and TPT groups (p<0.05). 
Fig.3: Calibration curve obtained by the amount of fluorescence intensities of the control group and DNase- treated grousps. 3.4 changes 
in amount of fluorescence intensity indicated a 1% break in DNA. Data are presented as mean ± SEM.
Y; Fluorescence intensity, X; Percent of digestion, R; Regression coefficient and SEM; Standard error of the mean. 
Fig.4: Distribution of the average percentage of single-strand breaks (SSB) and double-strand breaks (DSB) of glioblastoma (GBM) cells in 
groups irradiated (2Gy of beta I-131) and treated with topotecan (TPT). Data are presented as mean ± standard error of the mean (SEM).
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Reduction in DSB and SSB
In order to determine the amount of repair, we 
evaluated the DNA damage for a seven day pe-
riod at 24 hour intervals after radiation and treat-
ment by using the picogreen assay. Figures 5 and 6 
show the reduction DNA damage in the I-131 and 
I-131+TPT groups for 7 days after treatment. A 
decrease in the amount of DNA damage indicated 
the amount of repair in the I-131 irradiated groups 
in the presence or absence of TPT. The maximum 
rate of DNA repair occurred 24 hours after irra-
diation and treatment. A significant difference was 
not observed on other days of the restoration. The 
amount of SSB repair was more than the amount 
of DSB repair. The amount of restoration of DNA 
damage in the I-131 group was greater than the I-
131+TPT group.
Fig.5: Distribution of the average percentage of single-strand (SSB) and double-strand (DSB) of glioblastoma (GBM) cells in groups ir-
radiated with 2Gy of beta iodine-131 (I-131) for 7 days after radiation. Data are presented as mean ± standard error of the mean (SEM). 
Fig.6: Distribution of the average percentage of single-strand breaks (SSB) and double-strand breaks ( DSB) of glioblastoma (GBM) cells 
in groups irradiated with2Gy of beta iodine (I-131) and treated with topotecan (TPT) after 7 days of radiation and treatment. Data are 
presented as mean ± standard error of the mean (SEM). 
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PE and SF
The average numbers of PE efficiency for the 
GBM cell line in the control group are shown in ta-
ble 2. Maximum PE was observed when 5000 cells 
were seeded into flasks (3.36%). The fraction of 
cells that survived and PE in irradiated and treated 
groups are shown in figures 7 and 8. In figure 7, the 
I-131+TPT group had a decreased percentage of 
PE compared with the I-131 group (p<0.05). Fur-
thermore, cell death significantly increased in the 
presence of I-131+TPT compared with the I-131 
group (p<0.05). As seen in figure 8, SF in the I-
131+TPT group (39%) was less than I-131 group 
(58.92%).
Correlation between DNA damage and cell death
In table 3, the Pearson correlation coefficient anal-
ysis revealed that the relationship between cell death 
and DNA damage was close (r≥0.6) and significant 
(p<0.05) in the irradiated and treated groups.
Table 2: Average number of colonies and plating efficiency (PE) for glioblastoma GBM) cell line in  the control group 
PE (%)ColoniesCell number
2.5  ± 0.1875  ± 5.423000
2.8  ± 0.17112  ± 6.804000
3.36  ± 0.06168  ± 3.005000
3.28  ± 0.09197  ± 5.406000
3.18  ± 0.07223  ± 4.947000
Data are presented as mean ± standard error  of the mean (SEM). 
Fig.7: Plating efficiency (PE) for glioblastoma (GBM) cell line in control, iodine- 131 (I-131)+topotecan (TPT) and I-131 groups. Data are 
presented as mean ± standard error of the mean (SEM). 
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Fig.8: Fraction of cells that survived for the glioblastoma (GBM) cell line in  the iodine-131 (I-131)+topotecan (TPT) and I-131 groups. Data 
are presented as mean ± SEM.
SEM; Standard error of the mean and SF; Survival factor.
Table 3: Comparison of cell death and DNA damage in glioblastoma (GBM) cells in the iodine-131 (I-131) and I-131+topotecan (TPT) 
groups according to the colonogenic and picogreen assays and their correlation (p<0.05)
P valuePearson coefficient (r)Mean cell death 
(%)
Mean DNA damage 
(%)
Group
0.0400.9141.0851.14I-131
0.0370.976166.58I-131+TPT
Discussion
TPT has a commercial name of Hycamtin. It 
is a radiosensitizer and one of the more recent 
chemotherapy drugs used for studies both in vitro 
and in vivo. TPT is derived from camptothecin (8, 
11, 27). This compound is used as treatment for a 
vast array of cancers such as ovarian, lung, leu-
kemia, non-Hodgkin’s lymphoma, myelodysplas-
tic syndrome, melanoma and colorectal cancers. 
Recently, research is being performed on GBM in 
children and adults (8). TPT inhibits the enzyme 
Topo-I and binds to DNA to form an isomerase 
DNA complex and aggregation of the stabilized 
complex which leads to SSB and DSB damage and 
finally cell death (28).
Scientific erosion and experimental study have 
shown an increased complexity and severity of 
complex DNA damage with increasing LET (29). 
High-LET radiation can produce up to 25 damages 
compared with 10 per cluster in low-LET radia-
tion (30). Complex DNA damages are difficult to 
repair, and may lead to cell death (31).
 CELL JOURNAL(Yakhteh), Vol 17, No 1, Spring 2015 108
Combination of Chemotherapeutic Agent with Beta Particle
The purpose of the current study was to apply 
picogreen assay as an evaluation of DNA damage 
and colonogenic assay to assess cell death caused 
by I-131 in the presence of TPT. We used 300 µm 
diameter spheroid cultures of the human GBM cell 
line U87MG. Ultimately, these two techniques 
would compare the relation between DNA damage 
and cell death.
Our results showed significantly increase 
DSB and SSB damages in the presence of TPT 
after beta radiation with I-131 compared with 
only I-131. Cell death also significantly in-
creased after radiation with I-131 and incuba-
tion with TPT for two hours as compared with 
the I-131 group.  Using TPT which inhibits 
the Topo-I enzyme and forms a complex on 
the DNA (32), we observed a higher level of 
DNA damage induced by radiation with I-131 
after incubation with TPT. The relation between 
DNA damage and cell death was closer in the 
I-131+TPT group (1.09) compared to the I-131 
group (1.24). Therefore, we concluded that the 
picogreen method was useful for predicting co-
lonogenic assay following exposure to genotox-
ic agents and beta irradiation with I-131. This 
could be due to increasingly complex DNA 
damage, particularly DSB damage in the pres-
ence of genotoxic agents and high LET radia-
tion of beta I-131.
Previous study has reported that up to 90% of 
complex DSB are created by high LET radiation; 
whereas 30% of those are created by low LET 
radiation (31). On the other hand, repair of com-
plex DNA damage rarely occurs, rather there is 
cell death and the formation of chromosome aber-
rations (33, 34). Barazzuol et al. (35) have dem-
onstrated that high LET radiation combined with 
temozolomide (TMZ) had an enormous potential 
for treating a radioresistant tumor such as GBM.
Banath et al. (20) reported that residual γH2AX 
predicted colonogenic fraction subsequent to ex-
posure to cisplatin, TMZ and camptothecin (CPT) 
drugs in SiHa cervical cancer cells.
The current study results revealed that the per-
centage of DSB (12%) and SSB (16%) repairs 
were greater in the I-131 group compared to the I-
131+TPT group (DSB: 7.50%) (SSB: 10.49%) at 24 
hours after treatment. Since DNA repair mechanisms 
were disturbed in the I-131+TPT group, the resultant 
damages were very severe. Our results indicated that 
the repair of DSB was (12%) at 24 hours after irradia-
tion with 2 Gy in GBM cells (36).
Chu et al. (37) observed that repair of DSB was 
(10%) at 6 hours after irradiation with 2 Gy the 
presence of BO-1051 in cell line U87MG. Ma et 
al. (38) reported that the repair of DSB was less 
than the repair of SSB in a Raji cell line after γ- 
irradiation with 100 Gy using epstein-barr virus 
(EBV). 
Conclusion
Treatment of cells with TPT after I-131 beta 
radiation has significantly increased complex 
DNA damage and may improve the therapeu-
tic index for radiation. Our purpose for further 
studies is to use TPT liposomes modified with 
tamoxifen (TAM) and wheat germ agglutinin 
(WGA) to improve drug transport across the 
blood-brain barrier, develop drug stabilization, 
and subsequently evaluate the combined effects 
of these agents on cells.
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